U.S. Trade Distributors Stock News

MannKind Corporation reported past fourth-quarter 2025 results with revenue rising to US$111.96 million, but swinging from prior net income to a US$15.95 million net loss, while full-year 2025 revenue increased to US$348.97 million alongside a lower net income of US$5.86 million. A key risk emerged as partner United Therapeutics recently unveiled a competing soft-mist treprostinil inhaler that could challenge MannKind’s Tyvaso DPI royalty stream, increasing uncertainty around the company’s...

Easterly Government Properties (DEA) focuses on Class A properties leased to U.S. government agencies, and its stock has seen mixed returns, with a monthly gain alongside a negative 1-year total return. See our latest analysis for Easterly Government Properties. At a share price of $23.28, Easterly Government Properties has a 30 day share price return of 3.28% and a year to date share price return of 9.24%. The 1 year total shareholder return of 9.89% and 5 year total shareholder return of...

The immediate implementation of Section 1709 of the FY25 NDAA, which restricts foreign-made drone components, together with a new Pentagon Drone Dominance Program contract, has put fresh attention on Red Cat Holdings (RCAT) and its expanding unmanned systems portfolio. See our latest analysis for Red Cat Holdings. At a share price of $11.65, Red Cat has seen a 67.14% 90 day share price return and a very large 3 year total shareholder return. However, recent 1 day and 30 day share price moves...

In recent days, FS KKR Capital Corp., a major credit vehicle managed by KKR, cut its quarterly dividend by 31% after reporting increased troubled loans, lower investment income, and portfolio markdowns, particularly across software-related exposures. These developments have intensified market focus on credit quality, income resilience, and the health of private credit portfolios tied to KKR’s broader platform. These stresses sit alongside KKR’s ongoing portfolio reshaping, including a...

Seadrill (NYSE:SDRL) reported record operational and safety performance, marking its best safety results to date. The company secured several long term contracts, including a key award in Malaysia in the deepwater segment. Management highlighted strong execution on complex offshore projects alongside ongoing market challenges such as high reactivation costs and regional softness. At a share price of $43.88, Seadrill is drawing attention as it pairs operational execution with what the...

Circle Internet Group (CRCL) is back in focus after its fourth quarter 2025 earnings comfortably beat forecasts on revenue and profitability, helped by stronger USDC usage, heavier onchain volumes, and higher reserve income. See our latest analysis for Circle Internet Group. After the initial post earnings surge, Circle Internet Group’s recent 7 day share price return of 32.4% and 30 day share price return of 23.5% suggest momentum is still building despite a softer 1 day move. If Circle’s...

In February 2026, RWS Global announced it had selected Box as its Intelligent Content Management partner, adopting Box Enterprise Advanced and Box AI to modernize how vast volumes of unstructured content are governed, automated and embedded into workflows across its global experiential operations. A distinctive aspect of this partnership is RWS Global’s use of Box’s AI-powered contract automation, which cuts contract processing times from up to 20 minutes to under two minutes per contract,...

In February 2026, Tower Semiconductor and partners Salience Labs, Xanadu, and Scintil Photonics announced expanded collaborations to manufacture advanced silicon photonics solutions for AI data centers and photonic quantum computing, moving several programs onto Tower's high-volume platforms and into pre-production readiness. These deals collectively highlight Tower's role as a manufacturing backbone for cutting-edge photonic technologies that could underpin next-generation AI networking and...

If you are wondering whether American Healthcare REIT is attractively priced at around US$52.24, you are not alone. Many investors are asking if the recent run reflects its true value or if there is still room on the table. The stock has returned 0.6% over the last 7 days, 10.6% over the past month, and 80.1% over the past year, which naturally raises questions about how risk and reward now stack up. Recent coverage has focused on American Healthcare REIT as a healthcare focused real estate...

Why General Electric stock is on investors’ radar General Electric (GE) has drawn fresh attention after recent trading, with the share price near $342.26 and returns over the past month and past 3 months outpacing its single day and weekly moves. See our latest analysis for General Electric. That recent 17.02% 1 month share price return and 14.68% 3 month share price return sit alongside a 66.30% 1 year total shareholder return and a very large 5 year total shareholder return. Together, these...

MKS Inc. (NasdaqGS:MKSI) CEO John T.C. Lee is scheduled to appear at Morgan Stanley’s Technology, Media & Telecom Conference. Director Peter Cannone recently sold shares of MKS Inc., according to insider transaction disclosures. The company’s latest disclosed share price is $244.46. MKS Inc. comes into this news with a share price of $244.46 and a 1 year return of 168.2%, alongside a 45.2% return year to date. Over 3 years, the stock shows a 159.4% return and over 5 years a 66.0% return...

Wave Life Sciences has reported its fourth-quarter and full-year 2025 results, with quarterly revenue falling to US$17.24 million from US$83.75 million and the company moving from a net income of US$29.25 million to a net loss of US$53.18 million, while also outlining progress across its RNA-based obesity and alpha-1 antitrypsin deficiency programs. Despite wider losses, Wave highlighted interim obesity and alpha-1 antitrypsin deficiency data, a cash position of US$602.10 million funding...

In late February 2026, Phathom Pharmaceuticals reported fourth-quarter and full-year 2025 results showing a much smaller net loss of US$21.15 million for the quarter and US$221.25 million for the year, alongside guidance for 2026 that includes expected operating profitability (excluding stock-based compensation) beginning in the third quarter. The company also strengthened its financial position through a US$130 million equity raise, reworked term loans, and ongoing uptake of its VOQUEZNA...

Hershey's President, International has recently sold a substantial block of NYSE:HSY shares. This transaction adds to a wider pattern of insider selling at Hershey over the past year. The continued selling activity is material for investors tracking management sentiment and governance signals. Hershey, the maker of chocolate, confectionery, and snacks under brands many consumers know well, sits at the heart of the packaged food sector. For investors, insider activity at a company like this...

Arbor Realty Trust (ABR) just closed out FY 2025 with Q4 revenue of US$81.3 million and basic EPS of US$0.07, capping a year where trailing twelve month revenue came in at US$467.7 million and EPS at US$0.56. Over recent quarters the company has seen quarterly revenue range from US$111.1 million to US$140.7 million with EPS between US$0.12 and US$0.20, while trailing twelve month revenue has moved between US$467.7 million and US$650.4 million and EPS between US$0.56 and US$1.35. This sets the...

Tutor Perini Corporation recently reported fourth-quarter 2025 results, with sales of US$1,507.37 million and net income of US$28.84 million, and its Board declared a quarterly cash dividend of US$0.06 per share payable on March 26, 2026 to shareholders of record on March 10, 2026. The shift from a net loss in the prior year to profitability for both the quarter and full year highlights a material improvement in operating performance that may influence how investors view the company’s...

Event context and recent share performance Elevance Health (ELV) shares closed at US$320, with the stock showing a 1-day return of 0.94% and a 7-day decline of 6.69%, extending weaker performance over the past month and the past 3 months. See our latest analysis for Elevance Health. Looking beyond this week, Elevance Health’s share price return is weaker over the year, with a year to date share price decline of 9.67% and a 1 year total shareholder return of 17.81% in the red. This suggests...

AvePoint (AVPT) is back in focus after reporting Q4 and full year 2025 earnings, issuing 2026 revenue guidance, and filing a US$206.96 million shelf registration tied to an employee stock ownership plan. See our latest analysis for AvePoint. The earnings beat and AI-focused product updates have coincided with a 3.85% 1 day share price return. However, the 30 day and year to date share price returns of 9.56% and 18.46% declines, and a 27.84% decline in the 1 year total shareholder return,...

Amgen signalled a shift in focus toward growth leadership, backed by strong momentum from products such as Repatha. The company recently guided revenue higher following a strong quarterly update. Investors are watching for Phase 3 data on MariTide, Amgen’s obesity drug candidate, which could influence its growth story. For investors watching NasdaqGS:AMGN, the story is no longer only about dividends and stability. The share price stands at $388.16, with returns of 3.6% over the past week...

Luckin Coffee (OTCPK:LKNC.Y) has surpassed 30,000 stores in China, marking a new scale milestone in its domestic network. The company reports continued growth in overall revenue alongside a slowdown in same-store sales. Profit margins are under pressure as Luckin Coffee invests in rapid expansion and faces rising competition and costs. The brand is also expanding its international footprint, adding to its profile as a global coffee retailer. For investors following consumer and retail...

If you are wondering whether NetScout Systems is priced attractively right now, the recent share performance gives you a useful starting point but not the full story on value. The stock closed at US$29.21, with a 1.6% decline over the last 7 days, a 4.1% gain over 30 days, an 8.8% gain year to date, and a 29.9% return over the past year, while the 3 year and 5 year returns sit at 3.2% and 6.3% respectively. These moves come against a backdrop of ongoing interest in networking and...

Why Avnet Is On Investors’ Screens Right Now Avnet (AVT) has caught investor attention after a period where its shares show mixed short term returns but solid gains over the past 3 months and year to date, prompting fresh questions about valuation and fundamentals. See our latest analysis for Avnet. While Avnet’s share price has eased slightly in the last week, the 30 day share price return of 9.81% and 90 day gain of 38.58% suggest momentum has been building alongside a 1 year total...

Excelerate Energy, Inc. recently reported its fourth-quarter and full-year 2025 results, posting US$317.57 million in quarterly revenue and US$39.2 million in full-year net income, while slightly missing consensus earnings expectations in the final quarter. The company paired these record annual figures with fresh 2026 adjusted EBITDA guidance, updates on its Iraq LNG terminal and Jamaica integration, and a US$0.08 quarterly dividend, underscoring how growth projects and capital commitments...

Vital Farms stock moves after recent performance Vital Farms (VITL) has drawn investor attention after recent share price pressure, with the stock showing negative returns over the past week, month and past 3 months, prompting closer scrutiny of its current valuation. See our latest analysis for Vital Farms. At a share price of $21.09, Vital Farms has seen momentum fade recently, with a 30 day share price return of 25.87% and a 1 year total shareholder return of 36.3%, set against a 3 year...